These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22028149)

  • 1. Clinical implications of chemokines in acute and chronic hepatitis C virus infection.
    Kang W; Shin EC
    Yonsei Med J; 2011 Nov; 52(6):871-8. PubMed ID: 22028149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates.
    Li K; Li NL; Wei D; Pfeffer SR; Fan M; Pfeffer LM
    Hepatology; 2012 Mar; 55(3):666-75. PubMed ID: 22030901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations.
    Fallahi P; Ferrari SM; Giuggioli D; Sebastiani M; Colaci M; Ferri C; Antonelli A
    Curr Drug Targets; 2017; 18(7):786-793. PubMed ID: 26240054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C.
    Hengst J; Falk CS; Schlaphoff V; Deterding K; Manns MP; Cornberg M; Wedemeyer H
    J Infect Dis; 2016 Dec; 214(12):1965-1974. PubMed ID: 27683821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.
    Li H; Huang MH; Jiang JD; Peng ZG
    World J Gastroenterol; 2018 Dec; 24(47):5297-5311. PubMed ID: 30598575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunopathogenesis of hepatitis C virus infection.
    Nelson DR
    Clin Liver Dis; 2001 Nov; 5(4):931-53. PubMed ID: 11685802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine-Regulated Recruitment of Antigen-Specific T-Cell Subpopulations to the Liver in Acute and Chronic Hepatitis C Infection.
    Pirozyan MR; Nguyen N; Cameron B; Luciani F; Bull RA; Zekry A; Lloyd AR
    J Infect Dis; 2019 Apr; 219(9):1430-1438. PubMed ID: 30496498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of chemokines in acute and chronic hepatitis C infection.
    Fahey S; Dempsey E; Long A
    Cell Mol Immunol; 2014 Jan; 11(1):25-40. PubMed ID: 23954947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th17 and IL-17 immunity in chronic hepatitis C infection.
    Bălănescu P; Lădaru A; Voiosu T; Nicolau A; Ene M; Bălănescu E
    Rom J Intern Med; 2012; 50(1):13-8. PubMed ID: 22788089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
    Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
    Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?
    Ferrari SM; Fallahi P; Ruffilli I; Elia G; Ragusa F; Paparo SR; Patrizio A; Mazzi V; Colaci M; Giuggioli D; Ferri C; Antonelli A
    J Immunol Res; 2019; 2019():5878960. PubMed ID: 31485460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
    Zeremski M; Petrovic LM; Talal AH
    J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells.
    Nishitsuji H; Funami K; Shimizu Y; Ujino S; Sugiyama K; Seya T; Takaku H; Shimotohno K
    J Virol; 2013 Jul; 87(14):8169-78. PubMed ID: 23678168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C.
    Shin EC; Park SH; Demino M; Nascimbeni M; Mihalik K; Major M; Veerapu NS; Heller T; Feinstone SM; Rice CM; Rehermann B
    Gastroenterology; 2011 Aug; 141(2):686-95, 695.e1. PubMed ID: 21699897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL9 chemokine level is associated with spontaneous clearance and sustained virological response in Egyptian Chronic Hepatitis C patients receiving direct acting antivirals.
    Tabll AA; Afifi MS; El-Etrawy AS; El-Kousy SM; Smolic M; El Abd YS
    Hum Antibodies; 2020; 28(2):141-148. PubMed ID: 32675406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
    Baumert TF; Wellnitz S; Aono S; Satoi J; Herion D; Tilman Gerlach J; Pape GR; Lau JY; Hoofnagle JH; Blum HE; Liang TJ
    Hepatology; 2000 Sep; 32(3):610-7. PubMed ID: 10960457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections.
    Raziorrouh B; Sacher K; Tawar RG; Emmerich F; Neumann-Haefelin C; Baumert TF; Thimme R; Boettler T
    Gastroenterology; 2016 Mar; 150(3):696-706.e3. PubMed ID: 26584604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy.
    González-Aldaco K; Torres-Reyes LA; Ojeda-Granados C; José-Ábrego A; Fierro NA; Román S
    Ann Hepatol; 2018 Oct; 17(6):908-919. PubMed ID: 30600305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Development of Antiviral Therapies for Chronic Hepatitis C Virus Infection.
    Martinez MA; Franco S
    Adv Exp Med Biol; 2021; 1322():139-157. PubMed ID: 34258740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.